Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
The Journal of Urology|December 26, 2016
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled TrialVictor W Nitti, Roger Dmochowski, Sender Herschorn, et al.Acta Odontologica Scandinavica|December 30, 2016
Circadian rhythms and gene expression during mouse molar tooth developmentMinou Nirvani, Cuong Khuu, Tor Paaske Utheim, et al.Obstetrics and Gynecology|June 8, 2022
Transvaginal Mesh Compared With Native Tissue Repair for Pelvic Organ ProlapseBruce Kahn, R Edward Varner, Miles Murphy, et al.Current Cardiovascular Imaging Reports|March 5, 2016
Coronary Computed Tomography Angiography Derived Fractional Flow Reserve and Plaque StressBjarne Linde Nørgaard, Jonathon Leipsic, Bon-Kwon Koo, et al.Urology|June 15, 2019
A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder SyndromeKathleen Kobashi, Victor Nitti, Eric Margolis, et al.Scandinavian Journal of Clinical and Laboratory Investigation|July 28, 2017
Lack of association between cystatin C and different coronary atherosclerotic manifestationsTrine R Larsen, Oke Gerke, Axel C P Diederichsen, et al.Annals of Translational Medicine|July 15, 2017
Computer tomography guided lung biopsy using interactive breath-hold control: a randomized studyHaseem Ashraf, Shella Krag-Andersen, Matiullah Naqibullah, et al.Head & Neck|August 2, 2021
Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongueSushma Pandey, Tine Merete Søland, Inger Heidi Bjerkli, et al.International Urogynecology Journal|February 3, 2017
Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective studyShilpa Iyer, Elizabeth Lotsof, Ying Zhou, et al.The Journal of Urology|April 4, 2016
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year StudyVictor W Nitti, David Ginsberg, Karl-Dietrich Sievert, et al.Pageof 7